2023-503528-25-00已完成1 期
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal
F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年6月1日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Trial Information Support Line-TISL
Scientific
F. Hoffmann-La Roche AG
研究点 (1)
Loading locations...
相似试验
招募中
1 期
First in human clinical trial to evaluate the safety, tolerability and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer2022-503084-15-00Deutsches Krebsforschungszentrum (DKFZ)77
已完成
1 期
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with or without fluconazole2023-510472-31-00Janssen Cilag International18
招募中
1 期
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food2024-519615-34-00Boehringer Ingelheim International GmbH17
已完成
1 期
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood2023-506367-33-00Boehringer Ingelheim International GmbH16
已完成
1 期
A study in healthy men to test how different doses of BI 3000202 are tolerated and how food influences the amount of BI 3000202 in the blood2022-502424-43-00Boehringer Ingelheim International GmbH68